• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清抗 AP3D1 抗体是与动脉粥样硬化相关的急性缺血性脑卒中的危险因素。

Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.

机构信息

Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.

Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.

出版信息

Sci Rep. 2021 Jun 29;11(1):13450. doi: 10.1038/s41598-021-92786-9.

DOI:10.1038/s41598-021-92786-9
PMID:34188129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8242008/
Abstract

Atherosclerosis has been considered as the main cause of morbidity, mortality, and disability worldwide. The first screening for antigen markers was conducted using the serological identification of antigens by recombinant cDNA expression cloning, which has identified adaptor-related protein complex 3 subunit delta 1 (AP3D1) as an antigen recognized by serum IgG antibodies of patients with atherosclerosis. Serum antibody levels were examined using the amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA) using a recombinant protein as an antigen. It was determined that the serum antibody levels against AP3D1 were higher in patients with acute ischemic stroke (AIS), transient ischemic attack, diabetes mellitus (DM), cardiovascular disease, chronic kidney disease (CKD), esophageal squamous cell carcinoma (ESCC), and colorectal carcinoma than those in the healthy donors. The area under the curve values of DM, nephrosclerosis type of CKD, and ESCC calculated using receiver operating characteristic curve analysis were higher than those of other diseases. Correlation analysis showed that the anti-AP3D1 antibody levels were highly associated with maximum intima-media thickness, which indicates that this marker reflected the development of atherosclerosis. The results of the Japan Public Health Center-based Prospective Study indicated that this antibody marker is deemed useful as risk factors for AIS.

摘要

动脉粥样硬化被认为是全世界发病率、死亡率和残疾的主要原因。抗原标志物的首次筛选是通过重组 cDNA 表达克隆的血清学鉴定进行的,该鉴定确定衔接蛋白相关蛋白复合物 3 亚基 delta 1 (AP3D1) 为动脉粥样硬化患者血清 IgG 抗体识别的抗原。使用作为抗原的重组蛋白,通过扩增发光近同相分析联免疫吸附测定法 (AlphaLISA) 检查血清抗体水平。结果表明,与健康供体相比,急性缺血性脑卒中 (AIS)、短暂性脑缺血发作、糖尿病 (DM)、心血管疾病、慢性肾脏病 (CKD)、食管鳞状细胞癌 (ESCC) 和结直肠癌患者的血清 AP3D1 抗体水平更高。使用受试者工作特征曲线分析计算的 DM、CKD 肾硬化型和 ESCC 的曲线下面积值高于其他疾病。相关性分析表明,抗 AP3D1 抗体水平与最大内膜中层厚度高度相关,表明该标志物反映了动脉粥样硬化的发展。日本公共卫生中心前瞻性研究的结果表明,该抗体标志物可作为 AIS 的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/229190199cc0/41598_2021_92786_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/965386804907/41598_2021_92786_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/549f9ceea63e/41598_2021_92786_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/5033a6b9ab56/41598_2021_92786_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/2d4e700e46c7/41598_2021_92786_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/229190199cc0/41598_2021_92786_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/965386804907/41598_2021_92786_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/549f9ceea63e/41598_2021_92786_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/5033a6b9ab56/41598_2021_92786_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/2d4e700e46c7/41598_2021_92786_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c9/8242008/229190199cc0/41598_2021_92786_Fig5_HTML.jpg

相似文献

1
Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.血清抗 AP3D1 抗体是与动脉粥样硬化相关的急性缺血性脑卒中的危险因素。
Sci Rep. 2021 Jun 29;11(1):13450. doi: 10.1038/s41598-021-92786-9.
2
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.血清抗 DIDO1、抗 CPSF2 和抗 FOXJ2 抗体作为急性缺血性脑卒中的预测风险标志物。
BMC Med. 2021 Jun 9;19(1):131. doi: 10.1186/s12916-021-02001-9.
3
Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.血清抗 LRPAP1 是一种常见的消化器官癌症和动脉粥样硬化疾病的生物标志物。
Cancer Sci. 2020 Dec;111(12):4453-4464. doi: 10.1111/cas.14652. Epub 2020 Oct 4.
4
Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.血清抗 PCK1 抗体水平是糖尿病患者的预后因素。
BMC Endocr Disord. 2023 Oct 30;23(1):239. doi: 10.1186/s12902-023-01491-3.
5
Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.血清抗 ASXL2 抗体水平与急性缺血性脑卒中、急性心肌梗死、糖尿病、慢性肾脏病和消化器官癌的相关性及其与动脉粥样硬化和高血压的可能相关性。
Int J Mol Med. 2020 Oct;46(4):1274-1288. doi: 10.3892/ijmm.2020.4690. Epub 2020 Jul 29.
6
Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases.血清抗KIAA0513抗体作为致死性动脉粥样硬化和癌症疾病的常见生物标志物。
Med Int (Lond). 2024 Jun 19;4(5):45. doi: 10.3892/mi.2024.169. eCollection 2024 Sep-Oct.
7
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.抗集落刺激因子2的动脉粥样硬化相关血清抗体在预测急性缺血性卒中发病及结直肠癌预后中的应用
Front Cardiovasc Med. 2023 Feb 10;10:1042272. doi: 10.3389/fcvm.2023.1042272. eCollection 2023.
8
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.JMJD6 自身抗体作为炎症相关疾病的潜在生物标志物。
Int J Mol Sci. 2024 Apr 30;25(9):4935. doi: 10.3390/ijms25094935.
9
Elevation of Autoantibody in Patients with Ischemic Stroke.缺血性中风患者自身抗体水平升高。
Neurol Med Chir (Tokyo). 2018 Jul 15;58(7):303-310. doi: 10.2176/nmc.ra.2018-0022. Epub 2018 May 31.
10
Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.动脉粥样硬化疾病患者血清中抗DNAJC2自身抗体水平升高。
Heliyon. 2020 Aug 19;6(8):e04661. doi: 10.1016/j.heliyon.2020.e04661. eCollection 2020 Aug.

引用本文的文献

1
Research progress on remote ischemic conditioning for improving prognosis of patients with acute ischemic stroke.远程缺血预处理改善急性缺血性脑卒中患者预后的研究进展
Biochem Biophys Rep. 2025 Jul 30;43:102184. doi: 10.1016/j.bbrep.2025.102184. eCollection 2025 Sep.
2
Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases.血清抗KIAA0513抗体作为致死性动脉粥样硬化和癌症疾病的常见生物标志物。
Med Int (Lond). 2024 Jun 19;4(5):45. doi: 10.3892/mi.2024.169. eCollection 2024 Sep-Oct.
3
Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.

本文引用的文献

1
Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.血清抗 ASXL2 抗体水平与急性缺血性脑卒中、急性心肌梗死、糖尿病、慢性肾脏病和消化器官癌的相关性及其与动脉粥样硬化和高血压的可能相关性。
Int J Mol Med. 2020 Oct;46(4):1274-1288. doi: 10.3892/ijmm.2020.4690. Epub 2020 Jul 29.
2
Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.血清抗 LRPAP1 是一种常见的消化器官癌症和动脉粥样硬化疾病的生物标志物。
Cancer Sci. 2020 Dec;111(12):4453-4464. doi: 10.1111/cas.14652. Epub 2020 Oct 4.
3
血清抗 PCK1 抗体水平是糖尿病患者的预后因素。
BMC Endocr Disord. 2023 Oct 30;23(1):239. doi: 10.1186/s12902-023-01491-3.
4
GADD34 activates p53 and may have utility as a marker of atherosclerosis.生长停滞和DNA损伤诱导基因34(GADD34)激活p53,可能作为动脉粥样硬化的一个标志物。
Front Med (Lausanne). 2023 May 9;10:1128921. doi: 10.3389/fmed.2023.1128921. eCollection 2023.
5
Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels.对结直肠癌患者的分析显示,血清抗 ING1 自身抗体水平特异性升高。
BMC Cancer. 2023 Apr 18;23(1):356. doi: 10.1186/s12885-023-10845-y.
6
Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study.高蛋白酶原转化酶枯草溶菌素/克那霉 9 抗体水平与糖尿病患者预后不良相关:一项前瞻性研究。
Sci Rep. 2023 Apr 3;13(1):5391. doi: 10.1038/s41598-023-32644-y.
7
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.抗集落刺激因子2的动脉粥样硬化相关血清抗体在预测急性缺血性卒中发病及结直肠癌预后中的应用
Front Cardiovasc Med. 2023 Feb 10;10:1042272. doi: 10.3389/fcvm.2023.1042272. eCollection 2023.
8
Prognostic and diagnostic significance of preoperative Jumonji domain‑containing 6 antibodies in colorectal cancer.术前含Jumonji结构域蛋白6抗体在结直肠癌中的预后及诊断意义
Oncol Lett. 2023 Feb 10;25(3):127. doi: 10.3892/ol.2023.13713. eCollection 2023 Mar.
9
Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease.血清抗TSTD2抗体作为动脉粥样硬化性缺血性中风和慢性肾脏病的生物标志物。
Med Int (Lond). 2022 Dec 21;3(1):4. doi: 10.3892/mi.2022.64. eCollection 2023 Jan-Feb.
10
Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.血清抗BRAT1是胃肠道癌症和动脉粥样硬化的常见分子生物标志物。
Front Oncol. 2022 May 17;12:870086. doi: 10.3389/fonc.2022.870086. eCollection 2022.
Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
动脉粥样硬化疾病患者血清中抗DNAJC2自身抗体水平升高。
Heliyon. 2020 Aug 19;6(8):e04661. doi: 10.1016/j.heliyon.2020.e04661. eCollection 2020 Aug.
4
The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation.糖尿病与动脉粥样硬化的关联:脂质和葡萄糖代谢及慢性炎症的作用。
Int J Mol Sci. 2020 Mar 6;21(5):1835. doi: 10.3390/ijms21051835.
5
Autoantibodies as Potential Biomarkers in Breast Cancer.自身抗体作为乳腺癌潜在的生物标志物。
Biosensors (Basel). 2018 Jul 13;8(3):67. doi: 10.3390/bios8030067.
6
Elevation of Autoantibody in Patients with Ischemic Stroke.缺血性中风患者自身抗体水平升高。
Neurol Med Chir (Tokyo). 2018 Jul 15;58(7):303-310. doi: 10.2176/nmc.ra.2018-0022. Epub 2018 May 31.
7
Effects of cerebral small vessel disease on the outcome of patients with ischemic stroke caused by large artery atherosclerosis.脑小血管病对大动脉粥样硬化所致缺血性卒中患者预后的影响。
Neurol Res. 2018 May;40(5):381-390. doi: 10.1080/01616412.2018.1446283. Epub 2018 Mar 15.
8
Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.短暂性脑缺血发作患者中抗程序性细胞死亡蛋白11自身抗体水平的升高。
Oncotarget. 2017 Dec 24;9(10):8836-8848. doi: 10.18632/oncotarget.23653. eCollection 2018 Feb 6.
9
Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.血清中基质金属蛋白酶1、染色体盒蛋白1及染色体盒蛋白5抗体水平与短暂性脑缺血发作和脑梗死的关联
Oncotarget. 2017 Dec 31;9(5):5600-5613. doi: 10.18632/oncotarget.23789. eCollection 2018 Jan 19.
10
Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells.血管紧张素 -(1 - 7)可对抗血管紧张素 II 在乳腺癌细胞中引发的转化作用。
Oncotarget. 2017 Jul 17;8(51):88475-88487. doi: 10.18632/oncotarget.19290. eCollection 2017 Oct 24.